David Stokoe

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 5

Top Topics

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Oxidative Stress

Top Venues

Cancer research communications

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Lisa Choy, Stephen R Norris, Xiumin Wu, Ganesh Kolumam, Ari J Firestone, Jeffrey Settleman, David Stokoe
Inhibition of Aurora Kinase Induces Endogenous Retroelements to Induce a Type I/III IFN Response via RIG-I. Cancer research communications 4 (2) (2024)
Lisa Choy, Stephen R Norris, Xiumin Wu, Ganesh Kolumam, Ari J Firestone, Jeffrey Settleman, David Stokoe
Inhibition of Aurora Kinase Induces Endogenous Retroelements to Induce a Type I/III IFN Response via RIG-I. Cancer research communications 4 (2) (2024)
Lisa Choy, Stephen R Norris, Xiumin Wu, Ganesh Kolumam, Ari J Firestone, Jeffrey Settleman, David Stokoe
Inhibition of Aurora kinase induces endogenous retroelements to induce a type I/III interferon response via RIG-I. Cancer research communications (2024)
Steffan Vartanian, James Lee, Christiaan Kljin, Florian Gnad, Maria Bagniewska, Gabriele Schaefer, Donglu Zhang, Jenille Tan, Sara A Watson, Liling Liu, Honglin Chen, Yuxin Liang, Colin Watanabe, Trinna Cuellar, David Kan, Ryan J Hartmaier, Ted Lau, Michael R Costa, Scott E Martin, Mark Merchant, Benjamin Haley, David Stokoe
ERBB3 and IGF1R Signaling Are Required for Nrf2-Dependent Growth in KEAP1-Mutant Lung Cancer. Cancer research 79 (19) (2019)
Nicholas Dompe, Christiaan Klijn, Sara A Watson, Katherine Leng, Jenna Port, Trinna Cuellar, Colin Watanabe, Benjamin Haley, Richard Neve, Marie Evangelista, David Stokoe
A CRISPR screen identifies MAPK7 as a target for combination with MEK inhibition in KRAS mutant NSCLC. PloS one 13 (6) (2018)